Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes - Université de Rennes
Article Dans Une Revue Multiple Sclerosis Journal Année : 2017

Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes

Résumé

The therapeutic arsenal for preventing multiple sclerosis (MS) relapses strongly improved over the last 20 years with more than 10 disease-modifying drugs now available. However, relapses can still occur, requiring treatment with corticosteroids to accelerate recovery...

Domaines

Sciences du Vivant [q-bio]

Laurent Jonchère  : Connectez-vous pour contacter le contributeur

https://univ-rennes.hal.science/hal-01559941

Soumis le : mardi 11 juillet 2017-09:56:15

Dernière modification le : mardi 16 juillet 2024-15:14:04

Consulter le texte intégral

Dates et versions

hal-01559941 , version 1 (11-07-2017)

Identifiants

Citer

Emmanuelle Le Page, Gilles Edan. Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes. Multiple Sclerosis Journal, 2017, 23 (8), pp.1056--1058. ⟨10.1177/1352458517695893⟩. ⟨hal-01559941⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-RENNES1 CNRS INRIA INSA-RENNES IRISA CIC CIC203 CENTRALESUPELEC INRIA2 UR1-UFR-SVE UR1-MATH-STIC UR1-UFR-ISTIC UNIV-RENNES UR1-MATH-NUM UR1-BIO-SA
154 Consultations
0 Téléchargements

Altmetric

Partager

More